Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion
Authors
Keywords
Human genetics, Neuroblastoma, Chromosomal deletions, Genetics of disease, Gene amplification, Cancer treatment, Genetic networks, DNA
Journal
PLoS One
Volume 8, Issue 1, Pages e53740
Publisher
Public Library of Science (PLoS)
Online
2013-01-15
DOI
10.1371/journal.pone.0053740
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High Genomic Instability Predicts Survival in Metastatic High-Risk Neuroblastoma
- (2015) Sara Stigliani et al. NEOPLASIA
- Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma
- (2012) Simona Coco et al. INTERNATIONAL JOURNAL OF CANCER
- Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
- (2012) Jan J. Molenaar et al. NATURE
- Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
- (2011) G Schleiermacher et al. BRITISH JOURNAL OF CANCER
- How to minimise the effect of tumour cell content in detection of aberrant genetic markers in neuroblastoma
- (2011) M Piqueras et al. BRITISH JOURNAL OF CANCER
- CAMTA1, a 1p36 Tumor Suppressor Candidate, Inhibits Growth and Activates Differentiation Programs in Neuroblastoma Cells
- (2011) K.-O. Henrich et al. CANCER RESEARCH
- A Multilocus Technique for Risk Evaluation of Patients with Neuroblastoma
- (2011) I. M. Ambros et al. CLINICAL CANCER RESEARCH
- Prognostic value of partial genetic instability in neuroblastoma with ≤50% neuroblastic cell content
- (2011) Marta Piqueras et al. HISTOPATHOLOGY
- The FRA2C common fragile site maps to the borders of MYCN amplicons in neuroblastoma and is associated with gross chromosomal rearrangements in different cancers
- (2011) Anne Blumrich et al. HUMAN MOLECULAR GENETICS
- Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas
- (2011) Annelies Fieuw et al. INTERNATIONAL JOURNAL OF CANCER
- 2p24 Gain Region Harboring MYCN Gene Compared with MYCN Amplified and Nonamplified Neuroblastoma
- (2010) Marta Jeison et al. AMERICAN JOURNAL OF PATHOLOGY
- Chromosomal and MicroRNA Expression Patterns Reveal Biologically Distinct Subgroups of 11q- Neuroblastoma
- (2010) P. G. Buckley et al. CLINICAL CANCER RESEARCH
- Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
- (2010) S. De Brouwer et al. CLINICAL CANCER RESEARCH
- Accumulation of Segmental Alterations Determines Progression in Neuroblastoma
- (2010) Gudrun Schleiermacher et al. JOURNAL OF CLINICAL ONCOLOGY
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma
- (2010) Daniela Raguer Valadão de Souza et al. PEDIATRIC BLOOD & CANCER
- High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
- (2010) H. Caren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
- (2009) P F Ambros et al. BRITISH JOURNAL OF CANCER
- Heterogeneity of the MYCN Oncogene in Neuroblastoma
- (2009) J. Theissen et al. CLINICAL CANCER RESEARCH
- Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
- (2009) Isabelle Janoueix-Lerosey et al. JOURNAL OF CLINICAL ONCOLOGY
- Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
- (2009) Mario Capasso et al. NATURE GENETICS
- Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q
- (2009) M Fischer et al. ONCOGENE
- SNP Arrays in Heterogeneous Tissue: Highly Accurate Collection of Both Germline and Somatic Genetic Information from Unpaired Single Tumor Samples
- (2008) Guillaume Assié et al. AMERICAN JOURNAL OF HUMAN GENETICS
- CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23
- (2008) Evi Michels et al. BMC CANCER
- High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors; Four cases of homozygous deletions of the CDKN2A gene
- (2008) Helena Caren et al. BMC GENOMICS
- Characterization of amplicons in neuroblastoma: High-resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes
- (2008) Anne Fix et al. GENES CHROMOSOMES & CANCER
- Expression ofTSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation
- (2008) Kiyohiro Ando et al. INTERNATIONAL JOURNAL OF CANCER
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started